Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H9VQ
|
|||
| Former ID |
DNC013243
|
|||
| Drug Name |
L-norleucyl-L-prolinamide
|
|||
| Synonyms |
CHEMBL388843; L-norleucyl-L-prolinamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H21N3O2
|
|||
| Canonical SMILES |
CCCCC(C(=O)N1CCCC1C(=O)N)N
|
|||
| InChI |
1S/C11H21N3O2/c1-2-3-5-8(12)11(16)14-7-4-6-9(14)10(13)15/h8-9H,2-7,12H2,1H3,(H2,13,15)/t8-,9-/m0/s1
|
|||
| InChIKey |
AXARLGGBMIBEIZ-IUCAKERBSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tripeptidyl-peptidase II (TPP2) | Target Info | Inhibitor | [1] |
| Reactome | Antigen processing: Ubiquitination & Proteasome degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach ... J Med Chem. 2005 Nov 17;48(23):7333-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.